May 19, 2026
10 Fundamental patient rights essential for mitigating risks and preventing harm in healthcare settings.
10 Fundamental patient rights essential for mitigating risks and preventing harm in healthcare settings.
Three persistent myths continue to shape how pharmaceutical companies, biotechs, and even some regulators approach pharmacovigilance (PV), and each one carries a multi-million-dollar price tag.
Safety recommendations for two medicinal products: the CAR-T cell therapy axicabtagene ciloleucel (Yescarta) and the tyrosine kinase inhibitor ponatinib (Iclusig).
World Hand Hygiene Day, observed annually on 5 May, has for 18 years championed the single most effective measure to prevent healthcare-associated infections (HAIs): timely and proper hand hygiene.
Regulatory safety information on medicinal products from national pharmacovigilance centres worldwide and the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP).
Based on the WHO Guidelines for Malaria (August 2025) and Supporting Global Evidence
Medical overview of the history, types, and adverse effects of RPT, with a special focus on real-world pharmacovigilance data.
Advancing Medication Safety Through Knowledge and Vigilance